Dual blade ophthalmologic surgery device

Information

  • Patent Grant
  • 11464676
  • Patent Number
    11,464,676
  • Date Filed
    Tuesday, March 1, 2022
    2 years ago
  • Date Issued
    Tuesday, October 11, 2022
    2 years ago
Abstract
A dual blade device and method useable for performing an ab interno procedure within a human eye to remove a strip of trabecular meshwork tissue.
Description
BACKGROUND OF THE INVENTION

There are numerous medical and surgical procedures in which it is desirable to cut and remove a strip of tissue of controlled width from the body of a human or veterinary patient. For example, it may sometimes be desirable to form an incision of a controlled width (e.g., an incision that is wider than an incision made by a typical scalpel or cutting blade) in the skin, mucous membrane, tumor, organ or other tissue or a human or animal. Also, it may sometimes desirable to remove a strip or quantity of tissue from the body of a human or animal for use as a biopsy specimen, for chemical/biological analysis, for retention or archival of DNA identification purposes, etc. Also, some surgical procedures require removal of a strip of tissue of a known width from an anatomical location within the body of a patient.


One surgical procedure wherein a strip of tissue of a known width is removed from an anatomical location within the body of a patient is an ophthalmological procedure used to treat glaucoma. This ophthalmological procedure is sometimes referred to as a goniectomy. In a goniectomy procedure, a device that is operative to cut or ablate a strip of tissue of approximately 2-10 mm in length and about 50-200 μm in width is inserted into the anterior chamber of the eye and used to remove a full thickness strip of tissue from the trabecular meshwork. The trabecular meshwork is a loosely organized, porous network of tissue that overlies a collecting canal known as Schlemm's canal. A fluid, known as aqueous humor, is continually produced in the anterior chamber of the eye. In normal individuals, aqueous humor flows through the trabecular meshwork, into Schlemm's Canal and out of the eye through a series of ducts. In patients who suffer from glaucoma, the drainage of aqueous humor from the eye may be impaired by elevated flow resistance through the trabecular meshwork, thereby resulting in an increase in intraocular pressure. The goniectomy procedure can restore normal drainage of aqueous humor from the eye by removing a full thickness segment of the trabecular meshwork, thus allowing the aqueous humor to drain through the open area from which the strip of trabecular meshwork has been removed. The goniectomy procedure and certain prior art instruments useable to perform such procedure are described in U.S. patent application Ser. No. 10/052,473 published as No. 2002/011608A1 (Baerveldt), the entirety of which is expressly incorporated herein by reference.


At present there remains a need in the art for the development of simple, inexpensive and accurate instruments useable to perform the goniectomy procedure as well as other procedures where it is desired to remove a strip of tissue from a larger mass of tissue.


SUMMARY OF THE INVENTION

The present invention provides a device for cutting a strip of tissue of approximate width W from a mass of tissue. The device generally comprises a) an elongate cutting tube that has a distal end and a lumen that opens through an opening in the distal end and b) first and second cutting edges formed on generally opposite edges of the distal end of the cutting tube and separated by a distance D. The cutting tube is advanceable through tissue such that the first and second cutting edges will cut a strip of tissue having approximate width W, wherein the approximate width W is approximately equal to the distance D between the first and second cutting edges. In some embodiments, the strip of tissue may be aspirated or otherwise removed through the lumen of the cutter tube. In some embodiments, the device may include apparatus useable to sever (e.g., transversely cut or transect) the strip of tissue when the strip of tissue has reached a desired length.


Further in accordance with the invention there is provided a method for cutting a strip of tissue of width W from a tissue mass. This method generally comprises the steps of a) providing a device that comprises i) an elongate cutting tube that has a distal end and a lumen that opens through an opening in the distal end and ii) first and second cutting edges formed on generally opposite edges of the distal end of the cutting tube and separated by a distance D that is approximately equal to the width W of the strip of tissue to be cut; and b) advancing the distal end of the cutting tube through the mass of tissue such that the first and second cutting edges cut a strip of tissue of approximate width W. Further aspects and elements of the invention will be understood by those of skill in the art upon reading the detailed description of specific examples set forth here below.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective view of a system incorporating a needle cutting device of the present invention.



FIG. 2 is an enlarged perspective view of section 2 of FIG. 1.



FIGS. 3A-3D show various steps in a method for manufacturing a needle cutter of the present invention.



FIG. 4 is a side view of a distal portion of a needle cutter device of the present invention being used to cut a strip of tissue of approximate width W.



FIG. 5 is a perspective view of the distal portion of a needle cuter device of the present invention incorporating apparatus for severing a strip of tissue cut by the needle cutter device after the strip of tissue has reached a desired length.



FIG. 6 is a side view of the distal portion of another embodiment of a needle cutter device of the present invention having a plurality of curves or bends formed in the cutting tube.





DETAILED DESCRIPTION

The following detailed description, and the drawings to which it refers, are provided for the purpose of describing and illustrating certain preferred embodiments or examples of the invention only, and no attempt has been made to exhaustively describe all possible embodiments or examples of the invention. Thus, the following detailed description and the accompanying drawings shall not be construed to limit, in any way, the scope of the claims recited in this patent application and any patent(s) issuing therefrom.


One example of a needle cutter device 10 of the present invention is shown in FIGS. 1-4. This needle cutter device 10 generally comprises an elongate cutting tube 14 that has a distal end and a lumen 27 that opens through an opening in the distal end. First and second cutting edges 20, 22 are formed on generally opposite edges of the distal end of the cutting tube 14. These first and second cutting edges 20, 22 are separated by a distance D, as shown in the distal end view of FIG. 3B. In the particular example shown in the drawings, the first and second cutting edges 20, 22 are located on opposite lateral sides of the distal end of the cutting tube 14 and a blunt, protruding tip 24 is located on the bottom of the distal end of the cutting tube. Also, a blunt edge 26 is located at the top of the distal end of the cutting tube 14. Thus, only the lateral cutting edges 20, 22 are sharp and intended to cut tissue. The blunt, protruding tip 24 can, in some applications, be configured and used to facilitate insertion of the device 10 to its intended location and/or the blunt protruding tip 24 may be placed in an anatomical or man made grove or channel (e.g., Schlemm's Canal of the eye) such that it will then advance through the channel or groove and guide the advancement and positioning of the remainder of the device 10.


One or more bends or curves may optionally be formed in the cutting tube 14 to facilitate its use for its intended purpose. For example, in the embodiment of the device 10 shown in FIG. 2, a single bend 17 of approximately 90 is formed near the distal end of the cutting tube 14. In the embodiment of the device 10b shown in FIG. 6, two separate bends of approximately 90 degrees each are formed at spaced apart locations on the cutting tube 14, thereby giving the cutting tube 14 a generally U shaped configuration. It will be appreciated that any number of bends or curves, in any direction and of any severity may be formed in the cutting tube 14 to facilitate its use in specific procedures or to enable it to be inserted through tortuous anatomical channels of the body. In most cases, the degree of curvature in embodiments where a single bend or curve is formed will be between approximately 30 and approximately 90 degrees and in embodiments where more than one bend or curve are formed in the cutting tube 14 each such bend or curve will typically be between approximately 15 to approximately 90 degrees.


As shown in FIG. 4, when the cutting tube 14 is advanced through tissue, distal end first, the first and second cutting edges 20, 22 will cut a strip ST of tissue having approximate width W, such approximate width W being approximately equal to the distance D between the first and second cutting edges 20, 22. The severed strip ST of tissue will enter the lumen 27 of the cutting tube 14 as the device advances. Negative pressure may be applied to lumen 27 to aspirate the strip ST of tissue and/or fluid and/or other matter through lumen 27.


The device 10 may optionally include a second lumen. Such second lumen may be used for infusion of fluid through the device 10 or for other purposes. In the embodiment shown in FIGS. 1 and 2, the device 10 comprises an outer tube 16 in addition to the cutting tube 14. The cutting tube 14 is of smaller diameter than the outer tube 16 and the cutting tube 14 may extend through the lumen 19 of the outer tube 16 such that a distal portion of the cutting tube 14 extends out of and beyond the distal end of the outer tube 16, as may be seen in FIG. 2. The distal end of the outer tube 16 is tapered and in close approximation with the outer surface of the cutting tube 14. Fluid may be infused through the lumen 19 of the outer tube 16, through the space between the outer surface of the cutting tube 14 and the inner surface of the outer tube 16. Fluid that is infused through the lumen 19 of the outer tube 16 may flow out of one or more apertures 11 formed near the distal end of the outer tube.


In some embodiments, the device 10 may be equipped with severing apparatus for severing (e.g., transversely cutting or transecting) the strip ST of tissue to fully excise or detach the strip ST of tissue from the remaining tissue mass and/or from the body of a human or animal subject. Such severing apparatus may comprise any suitable type of tissue cutter such as a blade, scissor, guillotine, electrode(s), laser, energy emitting tissue cutter, mechanical tissue cutter, etc. FIG. 5 shows an example of an embodiment of the device 10a wherein monopolar or bipolar electrode(s) 40 are located on the distal end of the cutting tube 14. When it is desired to sever the strip ST of tissue, the electrode(s) is/are energized with sufficient energy to sever the strip ST, thereby disconnecting the strip ST from the remaining tissue mass and/or the body of the human or animal subject.


In some embodiments of the device 10, the cutting edges 20, 22 may be heated such that they will cauterize as the cut. As those of skill in the art will appreciate, such heating of the cutting edges 20, 22 may be accomplished by placement of electrode(s) near the cutting edges 20, 22 such that, when the electrode(s) is/are energized, the cutting edges 20, 22 will become heated to a temperature suitable for the desired cauterization function.


The needle cutter device 10 of the present invention may optionally be used as part of a system 12, as shown in FIG. 1. The basic components of the system 12 comprise an aspiration pump module 74 and a source of irrigation fluid 72, mounted on a surgical roller cart 70. Control of the console functions during procedures may be accomplished by an aspiration foot pedal 78 which controls an aspiration pump 74 and variation in the height of the source of infusion fluid 72 to change the gravity fed pressure or flow rate of infusion fluid through the device. A pinch valve, or other means, may also be incorporated in the console to control flow of the irrigation fluid to the needle cutter device 10. In embodiments that include apparatus (e.g., electrode(s)) for heating the cutting edges 20, 22 and/or for severing the strip ST of tissue (FIG. 5), the system 11 may additionally comprise an electrical current source, such as an electrosurgical generator 76 and electrosurgical foot pedal 80 which controls the electrosurgical generator to deliver desired amount(s) of energy to the electrode(s) or other electrical elements (e.g., resistance heater(s), etc.) on the device 10. As an option, all of the basic control functions of system 12 may be integrated into a single foot pedal to facilitate use.


The device 10 may be provided as a pre-sterilized, single-use disposable probe or tip that is attachable to a standard surgical irrigation/aspiration handpiece such as that commercially available as The Rhein I/A Tip System from Rhein Medical, Inc., Tampa, Fla. After the device 10 has been attached to the handpiece, it may be connected to any or all of the electrosurgical generator module 76, aspiration pump module 74 and the source of irrigation fluid 72, as shown. Thus, the device 10 may be fully equipped for irrigation, aspiration, and electrosurgical capabilities, as described herein.



FIGS. 3A-3D show an example of a method for manufacturing the cutting tube 14 from standard tubing (e.g., stainless steel hypodermic tubing). Initially, the distal end of a tube is cut to form the lateral cutting edges 20, 22, the protruding tip 24 and the blunt top edge 26. Thereafter, if it is desired to have one or more bends or curves in the cutting tube 14, angular cut out(s) 30 may be formed in the tube 14, as shown in FIG. 3C. Thereafter, the tube 14 is bent to bring the edges of each angular cut out 30 into apposition and weld, adhesive or other joining techniques are used to weld or join the apposed edges of the cut outs together, thereby forming the desired bend(s) or curve(s) in the cutting tube 14. Likewise, if it is desired to have one or more bends or curves in the cutting tube 14, the tube 14 may be directly bent to form said curves or bends without the use of angular cut outs(s) 30. It may be appreciated that the use of angular cut-out(s) 30 allow a tube 10 of a given diameter to incorporate a curve or angle in a more compact form than is possible by bending tubing 10 of a given diameter to said curve or angle without kinking or damaging tube 10.


The device 10 and system 12 are useable to perform a variety of procedures wherein it is desired to form an incision or opening of a desired width or to remove, from a mass of tissue, a strip ST of tissue of a desired width.


One particular procedure that may be performed to treat glaucoma, using the device 10 and system 12 of the present invention, is a goniectomy. As explained herein a goniectomy procedure is an ab interno surgical procedure wherein a sector of the trabecular meshwork is removed from the eye of the patient to facilitate drainage of aqueous humor from the anterior chamber of the eye through Schlemm's Canal and the associated collector channels, thereby relieving elevated intraocular pressure.


To perform a goniectomy procedure using the device 10, first a small incision is made in the cornea at about 3 o'clock in the left eye, or at about 9 o'clock in the right eye. A 1.5 mm slit knife may be used to make this incision.


The device 10 is attached to the source of irrigation fluid 72 (e.g., basic balanced salt solution) such that irrigation fluid will flow through lumen 19 of the outer tube 16 and out of outflow aperture 11. The device 10 is then inserted through the incision and into the anterior chamber of the eye (with irrigation flowing). In some cases, during the insertion of the device 10, the source of irrigation fluid 72 may initially connected to the device such that the irrigation fluid will flow through the lumen 27 of the cutter tube 14. In this manner, irrigation fluid will begin to infuse into the anterior chamber of the eye as soon as the distal end of the cutter tube 14 has entered the anterior chamber, rather than being delayed until the larger outer tube 16 and aperture 11 have been advanced through the incision and into the anterior chamber. By this alternative approach, irrigation fluid may be caused to flow out of the distal end of the cutter tube 14 as the device 10 is being inserted, thereby spreading or opening the incision by hydraulic force while in addition increasing the fluid pressure in the anterior chamber. Such spreading or opening of the incision may facilitate advancement of the larger diameter outer tube 16 through the incision. Pressurizing the fluid in the anterior chamber causes the anterior chamber to deepen and may facilitate maneuvering of device 10 within the anterior chamber. In cases where this alternative approach is used, the source of infusion fluid 72 may be disconnected from lumen 27 of the cutter tube 14 after the device 10 has been inserted into the anterior chamber and, thereafter, the infusion fluid source 72 may be reconnected to lumen 19 of outer tube 16 such that infusion fluid will flow out of aperture 11. Negative pressure (e.g., via aspiration pump module 74) may then be applied to lumen 27 of the cutter tube 14 so as to aspirate fluid and debris through lumen 27 as shown in FIG. 4. The vertical height of the infusion fluid source 72 may be adjusted to provide sufficient gravity feed of infusion fluid to make up for the volume of fluid or matter being aspirated from the anterior chamber through lumen 27, thereby maintaining the desired pressure of fluid within the anterior chamber during the procedure.


A lens device (e.g., Ocular Swan-Jacob Autoclavable Gonioprism, Model OSJAG, Ocular Instruments Inc., Bellevue, Washington) may be positioned on the anterior aspect of the eye to enable the physician to clearly visualize the angle of the eye where the segment of trabecular meshwork is to be removed. Under direct visualization, the device 10 is advanced until the distal tip of the cutter tube 14 is positioned adjacent to the trabecular meshwork at the location where the strip ST is to be removed. Thereafter, the protruding tip 24 is advanced through the trabecular meshwork and into Schlemm's Canal.


The device 10 is then advanced along Schlemm's Canal, thereby causing the cutting edges 20, 22 to cut a strip of the trabecular meshwork, thereby creating an opening through which aqueous humor may drain from the anterior chamber of the eye.


After a strip of tissue of the desired length (e.g., about 2-10 mm) has been cut by the lateral cutting edges 20, 22, any optional tissue severing apparatus (e.g., electrode(s) 40 may be used (if present) to transect or sever the strip ST of tissue thereby disconnecting it from the patient's body and allowing it to be aspirated or drawn into or through lumen 27.


Thereafter, the aspiration is stopped, the device 10 is removed from the eye, and the infusion is stopped.


Following completion of the surgery, aqueous humor will drain from the anterior chamber through the opening that was created by removal of the strip of tissue from the trabecular meshwork™.


Although the invention has been described above with respect to certain embodiments and examples, it is to be appreciated that such embodiments and examples are non-limiting and are not purported to define all embodiments and examples of the invention. Indeed, those of skill in the art will recognize that various modifications may be made to the above-described embodiments and examples without departing from the intended spirit and scope of the invention and it is intended that all such modifications be included within the scope of the following claims.

Claims
  • 1. An ab interno method for forming an opening in trabecular meshwork of a patient's eye, said method comprising the steps of: obtaining a dual blade device that comprises a probe that extends along a first longitudinal axis,wherein the probe further comprising a distal portion that extends along a second longitudinal axis, the distal portion connected to the probe by a bend of an angle between approximately 30 degrees to approximately 90 degrees relative to the first longitudinal axis of the probe,wherein the distal portion comprises: a distal end comprising a transverse width, a top surface, a bottom surface, and a tip disposed on a bottom of the distal end, wherein said tip is tapered such that the transverse width of the distal end is narrowest at the tip and ends in a vertical edge relative to the bottom surface;wherein the distal end further comprises first and second lateral cutting edges, wherein the first and second lateral cutting edges are separated by a gap having a distance D, and wherein the first and second lateral cutting edges are configured to simultaneously cut tissue that passes over the top surface of the distal end and into contact with the first and second lateral cutting edges;wherein the bend comprises a rounded corner;andwherein the distal portion is sized to fit within Schlemm's Canal of the human eye;forming an opening into an anterior chamber of the eye;inserting the probe through the opening and into the anterior chamber;advancing the probe through the anterior chamber, to an operative position wherein the distal portion is positioned within Schlemm's Canal and the first and second lateral cutting edges are contacting the trabecular meshwork; and, thereaftercausing the distal portion to advance through Schlemm's Canal such that trabecular meshwork tissue passes over the top surface of the distal end and contacts the first and second lateral cutting edges;andcutting a strip of tissue having approximate width W with the first and second lateral cutting edges, from the trabecular meshwork, said approximate width W being approximately equal to the distance D between the first and second lateral cutting edges.
  • 2. The method of claim 1 further comprising the step of infusing fluid into the anterior chamber under controlled pressure to keep the anterior chamber filled with fluid during performance of the method.
  • 3. The method of claim 1 wherein the strip of tissue cut from the trabecular meshwork has a length of about 2 to 10 millimeters.
  • 4. The method of claim 1, further comprising the step of: disconnecting the strip of tissue from the trabecular meshwork such that it may be removed from the eye.
  • 5. The method of claim 4, wherein the disconnecting step comprises using a tissue severing apparatus to transect or sever the strip of tissue so as to disconnect it from the patient's body.
  • 6. The method of claim 1 further comprising the step of: removing the strip of tissue from the patient's eye.
  • 7. The method of claim 1, wherein the step of forming an opening into the anterior chamber of the eye comprises forming an incision through a cornea of the eye.
  • 8. The method of claim 1 wherein the method is performed under direct visualization through a lens device positioned on an anterior aspect of the eye.
  • 9. The method of claim 1 wherein the angle of the bend is approximately 90 degrees relative to the first longitudinal axis of the probe.
RELATED APPLICATIONS

This application is a continuation of copending U.S. patent application Ser. No. 17/115,922, filed Dec. 9, 2020, which is a continuation of U.S. patent application Ser. No. 15/714,909 filed Sep. 25, 2017 and issued as U.S. Pat. No. 10,888,460 on Dec. 22, 2020, which is a division of U.S. patent application Ser. No. 15/076,624 filed Mar. 21, 2016 and issued as U.S. Pat. No. 9,820,885 on Nov. 21, 2017, which is a continuation of U.S. patent application Ser. No. 14/789,632 filed Jul. 1, 2015 and issued as U.S. Pat. No. 9,358,155 on Jun. 7, 2016, which is a continuation of U.S. patent application Ser. No. 14/481,754 filed Sep. 9, 2014 and issued as U.S. Pat. No. 9,107,729 on Aug. 18, 2015, which is a division of U.S. patent application Ser. No. 13/159,356 filed Jun. 13, 2011 and now abandoned, which is a division of U.S. patent application Ser. No. 10/560,267 filed May 11, 2006 and issued as U.S. Pat. No. 7,959,641 on Jun. 14, 2011, which is a 35 U.S.C. § 371 national stage of PCT International Patent Application No. PCT/US2004/018488 filed Jun. 10, 2004, which claims priority to U.S. Provisional Patent Application No. 60/477,258 filed on Jun. 10, 2003, the entire disclosure of each such prior patent and application being expressly incorporated herein by reference.

US Referenced Citations (143)
Number Name Date Kind
421855 Burk Feb 1890 A
637463 Hegarty Nov 1899 A
2130949 Wharton Sep 1938 A
2220169 Murdock Nov 1940 A
2364333 Wisher Dec 1944 A
3294085 Wallace Dec 1966 A
3365798 Cunningham Jan 1968 A
3776238 Peyman et al. Dec 1973 A
3882872 Douvas et al. May 1975 A
3972117 Fogg Aug 1976 A
4011869 Seiler, Jr. Mar 1977 A
4111207 Seiler, Jr. Sep 1978 A
4255854 Bilbao Mar 1981 A
4365957 Das Dec 1982 A
4428748 Peyman et al. Jan 1984 A
4472879 Sizemore, Jr. Sep 1984 A
4501274 Skjaerpe Feb 1985 A
4559942 Eisenberg Dec 1985 A
4577629 Martinez Mar 1986 A
4649919 Thimsen et al. Mar 1987 A
4689040 Thompson Aug 1987 A
4706669 Schlegel Nov 1987 A
4712546 Noe Dec 1987 A
4753234 Martinez Jun 1988 A
4759746 Straus Jul 1988 A
4841984 Armeniades et al. Jun 1989 A
4900300 Lee Feb 1990 A
4955883 Nevyas et al. Sep 1990 A
4955887 Zirm Sep 1990 A
5019035 Missirlian et al. May 1991 A
5042008 Iwasa et al. Aug 1991 A
5112299 Pascaloff May 1992 A
5123904 Shimomura et al. Jun 1992 A
5163433 Kagawa et al. Nov 1992 A
5222959 Anis Jun 1993 A
5224950 Prywes Jul 1993 A
5269782 Sutter Dec 1993 A
5284472 Sussman et al. Feb 1994 A
5431646 Vassiliadis et al. Jul 1995 A
5431671 Nallakrishnan Jul 1995 A
5458596 Lax et al. Oct 1995 A
5478338 Reynard Dec 1995 A
5487747 Stegmann et al. Jan 1996 A
5529580 Kusunoki et al. Jun 1996 A
5540706 Aust et al. Jul 1996 A
5540708 Lim et al. Jul 1996 A
5558637 Allonen et al. Sep 1996 A
5569283 Green et al. Oct 1996 A
5681282 Eggers et al. Oct 1997 A
5733297 Wang Mar 1998 A
5755716 Garito et al. May 1998 A
5807277 Swaim Sep 1998 A
5817115 Nigam Oct 1998 A
5843106 Heisler Dec 1998 A
5865831 Cozean et al. Feb 1999 A
5885279 Bretton Mar 1999 A
5922003 Anctil et al. Jul 1999 A
5957881 Peters et al. Sep 1999 A
5957914 Cook et al. Sep 1999 A
5964777 Drucker Oct 1999 A
6004199 Habenicht et al. Dec 1999 A
6013049 Rockley et al. Jan 2000 A
6068629 Haissaguerre et al. May 2000 A
6213997 Hood et al. Apr 2001 B1
6217598 Berman et al. Apr 2001 B1
6241721 Cozean et al. Jun 2001 B1
6251103 Berlin Jun 2001 B1
6264668 Prywes Jul 2001 B1
6283961 Underwood et al. Sep 2001 B1
6290699 Hall et al. Sep 2001 B1
6293957 Peters et al. Sep 2001 B1
6382974 Garfinkel May 2002 B1
6388043 Langer et al. May 2002 B1
6419684 Heisler et al. Jul 2002 B1
6428501 Reynard Aug 2002 B1
6428539 Baxter et al. Aug 2002 B1
6432104 Durgin et al. Aug 2002 B1
6497712 Feaster Dec 2002 B1
RE38018 Anctil et al. Mar 2003 E
6557258 Roberts et al. May 2003 B1
6720402 Langer et al. Apr 2004 B2
6759481 Tong Jul 2004 B2
6979328 Baerveldt et al. Dec 2005 B2
7131975 Adams Nov 2006 B2
7244256 Decesare et al. Jul 2007 B2
7374566 Schossau May 2008 B1
7604663 Reimink et al. Oct 2009 B1
7632303 Stalker et al. Dec 2009 B1
7648591 Furst et al. Jan 2010 B2
7785321 Baerveldt et al. Aug 2010 B2
7842034 Mittelstein et al. Nov 2010 B2
7935131 Anthamatten et al. May 2011 B2
7955387 Richter Jun 2011 B2
7959641 Sorensen et al. Jun 2011 B2
8038923 Berger et al. Oct 2011 B2
8069546 Whittemore Dec 2011 B1
8147424 Kassab et al. Apr 2012 B2
9107729 Sorensen et al. Aug 2015 B2
9358155 Sorensen et al. Jun 2016 B2
9820885 Sorensen et al. Nov 2017 B2
10327947 Kahook Jun 2019 B2
10786391 Kahook Sep 2020 B2
10888460 Sorensen et al. Jan 2021 B2
20010034932 Macdonald Nov 2001 A1
20010053873 Schaaf et al. Dec 2001 A1
20020002372 Jahns et al. Jan 2002 A1
20020026205 Matsutani et al. Feb 2002 A1
20020038129 Peters et al. Mar 2002 A1
20020111608 Baerveldt et al. Aug 2002 A1
20030208217 Dan Nov 2003 A1
20040127927 Adams Jul 2004 A1
20040138685 Clague et al. Jul 2004 A1
20040153111 Hosoada Aug 2004 A1
20040204732 Muchnik Oct 2004 A1
20040210245 Erickson et al. Oct 2004 A1
20050090849 Adams Apr 2005 A1
20050159767 Adams et al. Jul 2005 A1
20060095055 Douglas et al. May 2006 A1
20060106370 Baerveldt et al. May 2006 A1
20060149194 Conston et al. Jul 2006 A1
20060149267 Nordt Jul 2006 A1
20060200180 Lee Sep 2006 A1
20060212060 Hacker et al. Sep 2006 A1
20060241580 Mittelstein et al. Oct 2006 A1
20070010812 Mittelstein et al. Jan 2007 A1
20070073275 Conston et al. Mar 2007 A1
20070149974 Mangione Jun 2007 A1
20070276420 Sorensen et al. Nov 2007 A1
20080077146 Pernsteiner et al. Mar 2008 A1
20090248141 Shandas et al. Oct 2009 A1
20090287233 Huculak Nov 2009 A1
20110077626 Baerveldt et al. Mar 2011 A1
20110230877 Huculak et al. Sep 2011 A1
20120071908 Sorensen et al. Mar 2012 A1
20120083727 Barnett Apr 2012 A1
20120123533 Shiuey May 2012 A1
20120191120 Linsi Jul 2012 A1
20140379015 Sorensen et al. Dec 2014 A1
20150045820 Kahook Feb 2015 A1
20150297400 Sorensen et al. Oct 2015 A1
20160220418 Sorensen et al. Aug 2016 A1
20180125712 Sorensen et al. May 2018 A1
20210113380 Sorensen et al. Apr 2021 A1
Foreign Referenced Citations (22)
Number Date Country
2 528 280 Dec 2012 CA
0 073 803 Mar 1983 EP
1 455 698 Sep 2004 EP
1 615 604 Jan 2006 EP
1 631 204 Mar 2006 EP
2 303 203 Apr 2011 EP
S4625677 Sep 1971 JP
H07-308320 Nov 1995 JP
2001-507590 Jun 2001 JP
2007-501687 Feb 2007 JP
10-2004-0058309 Jul 2004 KR
PA05013313 Aug 2006 MX
9117793 Nov 1991 WO
9827876 Jul 1998 WO
0178631 Oct 2001 WO
02056805 Jul 2002 WO
03045290 Jun 2003 WO
2004093761 Nov 2004 WO
2004110501 Dec 2004 WO
2009140185 Nov 2009 WO
2011030081 Mar 2011 WO
2013163034 Oct 2013 WO
Non-Patent Literature Citations (55)
Entry
“New World Medical to Launch the Kahook Dual Blade at AAO Meeting” press release tilled Oct. 21, 2015.
Am. Acad. Of Ophthalmology, Section 10 Glaucoma, in Basic and Clinical Science Course 2000-2001 (2000).
Am. Acad. Of Ophthalmology, Section 8 External Disease and Cornea, in Basic and Clinical Science Course.
Blacks Medical Dictionary 47th ed. (1992) excerpt at 519 (definition of “section”).
Decision to Grant a Patent Received for JP Patent Application No. 2006-533691, dated Sep. 14, 2010, 5 pages (Including English Translation).
Declaration of Dr. Peter Netland 2002.
Declaration of Garry P. Condon, M.D. submitted in 2021.
Deposition Transcript of Deposition of Garry Condon, M.D., Tuesday, Aug. 17, 2021.
Deposition Transcript of Deposition of Garry Condon, M.D., Tuesday, Aug. 18, 2021.
Dorland's Medical Dictionary Shorter Edition abridged from 25th ed. (1980) excerpt at 605 (definition of section).
Erin G. Sieck et al., “Outcomes of Kahook Dual blade Goniotomy with and without Phacoemulsification Cataract Extraction”, 1 Ophthalmology Glaucoma, pp. 75-81, 2018.
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2004/018488, dated Dec. 13, 2005 4 pages.
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2004/018488, dated Oct. 4, 2005 4 pages.
KDB Glide comparison to the TrabEx.
M. Bruce Shields, Textbook of Glaucoma, Fourth Edition. Baltimore, Maryland: Williams & Wilkins 1998.
Michael John Hogan, History of the Human Eye: An Atlas and Textbook. Philadelphia Pennsylvania: W. B. Saunders Company 1971.
Presentation by New World Medical tilled “KDB Competitive: Trabectome/Goniotome {MST}”.
Reply Declaration of Dr. Peter Netland 2021.
Supplementary European Search Report received for European Patent Application No. 04754925.8 dated Jan. 16, 2009 5 pages.
Todd Neff, UCHealth Eye Center lands global innovation awards, UCHealth Today, Jan. 6, 2016.
Transcript of Deposition of Dr. Peter Netland (Sep. 30, 2021).
Transcript of Deposition of Dr. Peter Netland May 27, 2021.
Transcript of Deposition of Dr. Peter Netland May 28, 2021.
Transcript of Oral argument conducted on Jan. 10, 2022.
University of Colorado a global leader in patents for inventions, innovations, CU Connections, Jun. 1, 2020.
Anderson, Douglas R., “Trabeculotomy Compared to Goniotomy for Glaucoma in Children”, Ophthalmology, vol. 90, No. 7, pp. 805-806, Jul. 1983.
Arora, et al., “K-RIM (Corneal Rim) Angle Surgery Training Model”, J Glaucoma, vol. 28, No. 2, pp. 146-149, Feb. 2019.
Bernard Becker, et al., Symposium: microsurgery of the outflow channels. Clinical research Trans Am Acad Ophthalmol Otolaryngol., Mar.-Apr. 1972, vol. 76, No. 2, pp. 405-410, 1972.
Dominguez, A “Ab Interno Trabeculotomy”, Bulletins et memoires de la Societe francaise. vol. 86, 1973.
Ferrari, et al., “Ab-interno Trabeculo-Canalectomy: Surgical Approach and Histological Examination”, European Journal of Ophthalmology, vol. 12, No. 5, pp. 401-405, 2002.
Francis, et al., “Ab Interno Trabeculectomy: Development of a Novel Device (Trabectome™) and Surgery for Open-Angle Glaucoma”, Journal of Glaucoma, vol. 15, No. 1, pp. 68-73, Mar. 2006.
Grant, Morton “Experimental Aqueous Perfusion in Enucleated Human Eyes”, Archives of Ophthalmology, vol. 69, No. 6, pp. 783-801, Jun. 1963.
Grant, W. M. “Clinical Measurements of Aqueous Outflow”, AMA Archives of Ophthalmology, vol. 46, No. 2, pp. 113-131, 1951.
Herschler, et al. “Modified Goniotomy for Inflammatory Glaucoma, Histologic Evidence for the Mechanism of Pressure Reduction”, Archives of Ophthalmology, vol. 98, No. 4, pp. 684 687, Apr. 1980.
Jacobi, et al., “Goniocurettage for Removing Trabecular Meshwork: Clinical Results of a New Surgical Technique in Advanced Chronic Open-Angle Glaucoma”, American Journal of Ophthalmology, vol. 127, No. 5, pp. 505-510, May 1999.
Jacobi, et al., “Technique of Goniocurettage: A Potential Treatment for Advanced Chronic open Angle Glaucoma”, British Journal of Ophthalmology, vol. 81, No. 4, pp. 302-307, 1997.
Jea, et al., “Ab Interno Trabeculectomy Versus Trabeculectomy for Open-Angle Glaucoma”, Ophthalmology, vol. 119, No. 1, pp. 36-42, Jan. 2012.
Johnson, et al., “Human Trabecular Meshwork Organ Culture. A New Method”, Investigative Ophthalmology & Visual Science, vol. 28, No. 6, pp. 945-953, Jun. 1987.
Jonathan Herschler, et al., “Modified Goniotomy for Inflammatory Glaucoma: Histologic Evidence for the Mechanism of Pressure Reduction”, Arch Ophthalmol, vol. 98, No. 4, pp. 684-687, 1980.
Luntz, et al., “Trabeculotomy Ab Extemo and Trabeculectomy in Congenital and Adult-Onset Glaucoma”, American Journal of Ophthalmology, vol. 83, No. 2, pp. 174-179, Feb. 1977.
Minckler, et al., “Clinical Results With the Trabectome for Treatment of Open-Angle Glaucoma”, Ophthalmology, vol. 112, No. 6, pp. 962-967, Jun. 2005.
Minckler, et al., “Clinical Results With The Trabectome, A Novel Surgical Device For Treatment Of Open-Angle Glaucoma”, Trans Am Ophthalmol Soc, vol. 104, pp. 40-50, 2006.
William H. Spencer, M.D “Symposium: microsurgery of the outflow channels. Histological evaluation of microsurgical Glaucoma techniques” Trans Am Acad Ophthalmol Otolaryngo, vol. 76, No. 2, pp. 389-397, Mar.-Apr. 1972.
Pantcheva, et al. Ab Interno Trabeculectomy Middle East African Journal of Ophthalmology, vol. 17, No. 4, pp. 287-289, 2010.
Phillip C. Jacobi, et al., “Perspectives in Trabecular Surgery”, Eye, vol. 14, (Pt 3B)(3b), pp. 519-530, 2000.
Quigley, et al.,“ The number of people with glaucoma worldwide in 2010 and 2020”, British Journal of Ophthalmology, vol. 90, pp. 262-267, 2006.
Quintana, “Gonioscopic Trabeculotomy. First Results”, Second European Glaucoma Symposium, Helsinki, pp. 265-271, 1984.
Richard, Snell S., et al., “Clinical Anatomy of the Eye, Second Section”, Malden, Massachusetts: Blackwell Science, 1998.
Scheie, Harold G., “Stripping of Descemet's Membrane in Cataract Extraction”, TR.AM. Opth. Soc., vol. 62, pp. 140-152, 1964.
Seibold, et al., “Preclinical Investigation of Ab Interno Trabeculectomy Using a Novel Dual-Blade Device”, The American Journal of Ophthalmology, vol. 155, No. 3, pp. 524-529, 2013.
Skjaerpe, F “Selective Trabeculectomy. A Report of a New Surgical Method for Open Angle Glaucoma”, ACTA Ophthalmologica, vol. 61, pp. 714-727, 1983.
Soohoo, et al. Ab Interno Trabeculectomy in the Adult Patient Middle East African Journal of Ophthalmology, vol. 22, No. 1 pp. 25-29 Jan.-Mar. 2, pp. 25-29.
T. Shute “A Novel Technique for Ab Interno Trabeculectomy: Description of Procedure and Preliminary Results”, Am. Glaucoma Society 29th Annual Meeting Poster Abstracts 34-35, (available at: https://ags.planion.com/Web.User/Abstractoet?ACCOUNT =AGS&CONF=AM19&ABSID=12309), 2019.
Tan, et al., “Postoperative Complications After Glaucoma Surgery for Primary Angle-Closure Glaucoma vs Primary Open-Angle Glaucoma”, Archives of Ophthalmology, vol. 129, No. 8, pp. 987-992, Aug. 2011.
Ting, et al., “Ab Interno Trabeculectomy: Outcomes in Exfoliation Versus Primary Open-Angle Glaucoma”, Journal of Cataract & Refractive Surgery, vol. 38, No. 2, pp. 315-323, Feb. 2012.
Related Publications (1)
Number Date Country
20220183883 A1 Jun 2022 US
Provisional Applications (1)
Number Date Country
60477258 Jun 2003 US
Divisions (3)
Number Date Country
Parent 15076624 Mar 2016 US
Child 15714909 US
Parent 13159356 Jun 2011 US
Child 14481754 US
Parent 10560267 US
Child 13159356 US
Continuations (4)
Number Date Country
Parent 17115922 Dec 2020 US
Child 17683743 US
Parent 15714909 Sep 2017 US
Child 17115922 US
Parent 14789632 Jul 2015 US
Child 15076624 US
Parent 14481754 Sep 2014 US
Child 14789632 US